Terms: = Germ cell tumor AND ITK, PSCTK2, 3702, Q08881, ENSG00000113263, EMT, MGC126258, LYK, MGC126257 AND Treatment
361 results:
1. Expression of STAT3 and hypoxia markers in long-term surviving malignant glioma patients.
Dvorakova K; Skarkova V; Vitovcova B; Soukup J; Vosmikova H; Pleskacova Z; Skarka A; Bartos MC; Krupa P; Kasparova P; Petera J; Rudolf E
BMC Cancer; 2024 Apr; 24(1):509. PubMed ID: 38654280
[TBL] [Abstract] [Full Text] [Related]
2. Phospholipid scramblase 1 acts through the IL-6/JAK/STAT3 pathway to promote the malignant progression of glioma.
Zhou S; Xu J; Zhu Y
Arch Biochem Biophys; 2024 Jun; 756():110002. PubMed ID: 38636689
[TBL] [Abstract] [Full Text] [Related]
3. Targeting Group 3 Medulloblastoma by the Anti-PRUNE-1 and Anti-LSD1/KDM1A Epigenetic Molecules.
Bibbò F; Asadzadeh F; Boccia A; Sorice C; Bianco O; Saccà CD; Majello B; Donofrio V; Bifano D; De Martino L; Quaglietta L; Cristofano A; Covelli EM; Cinalli G; Ferrucci V; De Antonellis P; Zollo M
Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612726
[TBL] [Abstract] [Full Text] [Related]
4. Salvianolic Acid B Significantly Suppresses the Migration of Melanoma cells via Direct Interaction with β-Actin.
Zhang Y; Zhai W; Fan M; Wu J; Wang C
Molecules; 2024 Feb; 29(4):. PubMed ID: 38398656
[TBL] [Abstract] [Full Text] [Related]
5. Characterization of a germline variant TNS1 c.2999-1G > C in a hereditary cancer syndrome family.
Di X; Wang D; Wu J; Zhu X; Wang Y; Yan J; Wen L; Jiang H; Wen D; Shu B; Zhang S
Gene; 2024 May; 908():148304. PubMed ID: 38387708
[TBL] [Abstract] [Full Text] [Related]
6. MicroRNAs in adult high-grade gliomas: Mechanisms of chemotherapeutic resistance and their clinical relevance.
Jegathesan Y; Stephen PP; Sati ISEE; Narayanan P; Monif M; Kamarudin MNA
Biomed Pharmacother; 2024 Mar; 172():116277. PubMed ID: 38377734
[TBL] [Abstract] [Full Text] [Related]
7. MZ1, a BRD4 inhibitor, exerted its anti-cancer effects by suppressing SDC1 in glioblastoma.
Li G; Ma L; Feng C; Yin H; Bao J; Wu D; Zhang Z; Li X; Li Z; Yang C; Wang H; Fang F; Hu X; Li M; Xu L; Xu Y; Liang H; Yang T; Wang J; Pan J
BMC Cancer; 2024 Feb; 24(1):220. PubMed ID: 38365636
[TBL] [Abstract] [Full Text] [Related]
8. Aberrant
Al-Ghabkari A; Huang B; Park M
Cells; 2024 Jan; 13(3):. PubMed ID: 38334610
[TBL] [Abstract] [Full Text] [Related]
9. HTRA1 promotes emt through the HDAC6/Ac-α-tubulin pathway in human GBM cells.
Zhao W; Wu Y; Wang S; Zhao F; Liu W; Xue Z; Zhang L; Wang J; Han M; Li X; Huang B
CNS Neurosci Ther; 2024 Feb; 30(2):e14605. PubMed ID: 38334007
[TBL] [Abstract] [Full Text] [Related]
10. The CoREST repressor complex mediates phenotype switching and therapy resistance in melanoma.
Wu M; Hanly A; Gibson F; Fisher R; Rogers S; Park K; Zuger A; Kuang K; Kalin JH; Nocco S; Cole M; Xiao A; Agus F; Labadorf A; Beck S; Collard M; Cole PA; Alani RM
J Clin Invest; 2024 Feb; 134(6):. PubMed ID: 38300709
[TBL] [Abstract] [Full Text] [Related]
11. IKBKE promotes the ZEB2-mediated emt process by phosphorylating HMGA1a in glioblastoma.
Sun Y; Guo G; Zhang Y; Chen X; Lu Y; Hong R; Xiong J; Li J; Hu X; Wang S; Liu Y; Zhang Z; Yang X; Nan Y; Huang Q
Cell Signal; 2024 Apr; 116():111062. PubMed ID: 38242271
[TBL] [Abstract] [Full Text] [Related]
12. EMP3 as a prognostic biomarker correlates with emt in GBM.
Li L; Xia S; Zhao Z; Deng L; Wang H; Yang D; Hu Y; Ji J; Huang D; Xin T
BMC Cancer; 2024 Jan; 24(1):89. PubMed ID: 38229014
[TBL] [Abstract] [Full Text] [Related]
13. OTX1 regulates tumorigenesis and metastasis in glioma.
Cao B; Liu K; Tian C; He H; He S; Chen H; Zhang X; Liu Y; Wang L; Liu X; Li M; Jia Q; Chai J
Pathol Res Pract; 2024 Feb; 254():155116. PubMed ID: 38218040
[TBL] [Abstract] [Full Text] [Related]
14. CRABP2 regulates infiltration of cancer-associated fibroblasts and immune response in melanoma.
Zeng S; Chen XI; Yi Q; Thakur A; Yang H; Yan Y; Liu S
Oncol Res; 2023; 32(2):261-272. PubMed ID: 38186580
[TBL] [Abstract] [Full Text] [Related]
15. A TCF4-dependent gene regulatory network confers resistance to immunotherapy in melanoma.
Pozniak J; Pedri D; Landeloos E; Van Herck Y; Antoranz A; Vanwynsberghe L; Nowosad A; Roda N; Makhzami S; Bervoets G; Maciel LF; Pulido-Vicuña CA; Pollaris L; Seurinck R; Zhao F; Flem-Karlsen K; Damsky W; Chen L; Karagianni D; Cinque S; Kint S; Vandereyken K; Rombaut B; Voet T; Vernaillen F; Annaert W; Lambrechts D; Boecxstaens V; Saeys Y; van den Oord J; Bosisio F; Karras P; Shain AH; Bosenberg M; Leucci E; Paschen A; Rambow F; Bechter O; Marine JC
Cell; 2024 Jan; 187(1):166-183.e25. PubMed ID: 38181739
[TBL] [Abstract] [Full Text] [Related]
16. A novel PDPN antagonist peptide CY12-RP2 inhibits melanoma growth via Wnt/β-catenin and modulates the immune cells.
Feng C; Yu A; Wang Z; Wang K; Chen J; Wu Y; Deng T; Chen H; Hou Y; Ma S; Dai X; Huang L
J Exp Clin Cancer Res; 2024 Jan; 43(1):9. PubMed ID: 38167452
[TBL] [Abstract] [Full Text] [Related]
17. SECTM1 promotes the development of glioblastoma and mesenchymal transition by regulating the TGFβ1/Smad signaling pathway.
Yao Z; Zhang F; Qi C; Wang C; Mao M; Zhao C; Qi M; Wang Z; Zhou G; Jiang X; Xia H
Int J Biol Sci; 2024; 20(1):78-93. PubMed ID: 38164182
[No Abstract] [Full Text] [Related]
18. Inhibition of TGF-β1-induced epithelial-mesenchymal transition in gliomas by DMC-HA.
Shi L; Wang Z; Rong J; Fei X; Li X; He B; Gong W; Qian J
Aging (Albany NY); 2023 Dec; 15(24):15183-15195. PubMed ID: 38154100
[TBL] [Abstract] [Full Text] [Related]
19. A network pharmacology- and transcriptomics-based investigation reveals an inhibitory role of β-sitosterol in glioma via the EGFR/MAPK signaling pathway.
Xie Y; Chen Z; Li S; Yan M; He W; Li L; Si J; Wang Y; Li X; Ma K
Acta Biochim Biophys Sin (Shanghai); 2024 Feb; 56(2):223-238. PubMed ID: 38143380
[TBL] [Abstract] [Full Text] [Related]
20. Histone demethylase KDM4B accelerates the progression of glioblastoma via the epigenetic regulation of MYC stability.
Wang Z; Cai H; Li Z; Sun W; Zhao E; Cui H
Clin Epigenetics; 2023 Dec; 15(1):192. PubMed ID: 38093312
[TBL] [Abstract] [Full Text] [Related]
[Next]
